These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4686399)

  • 1. Production of hypertension with desoxycorticorticosterone acetate-impregnated silicone rubber implants.
    Ormsbee HS; Ryan CF
    J Pharm Sci; 1973 Feb; 62(2):255-7. PubMed ID: 4686399
    [No Abstract]   [Full Text] [Related]  

  • 2. The action of 1-tyrosine and arachidonic acid on the experimental hypertension in rat: physiopathogenic deductions.
    Laborit H; Valette N
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):489-504. PubMed ID: 4854635
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in renal vascular reactivity at various stages of deoxycorticosterone hypertension in rats.
    Berecek KH; Stocker M; Gross F
    Circ Res; 1980 May; 46(5):619-24. PubMed ID: 7363411
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypertension following adrenal enucleation and its absence during desoxycorticosterone treatment in Long-Evans rats.
    Hall CE; Ayachi S; Hall O
    Endocrinology; 1973 Apr; 92(4):1175-81. PubMed ID: 4686314
    [No Abstract]   [Full Text] [Related]  

  • 5. Microsealed drug delivery systems I: In vitro-in vivo correlation on subcutaneous release of desoxycorticosterone acetate and prolonged hypertensive animal model for cardiovascular studies.
    Chien YW; Rozek LF; Lambert HJ
    J Pharm Sci; 1978 Feb; 67(2):214-7. PubMed ID: 621640
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance of Fischer 344 rats to deoxycorticosterone hypertension.
    Hall CE; Hall O
    Life Sci; 1977 Apr; 20(7):1239-47. PubMed ID: 850474
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of guanosine and adenosine on experimental arterial hypertension in rats].
    Laborit H; Valette N
    Agressologie; 1974; 15(5):323-6. PubMed ID: 4466364
    [No Abstract]   [Full Text] [Related]  

  • 8. [The parathyroids and desoxycorticosterone acetate induced arterial hypertension in the rat].
    Berthelot A; Schleiffer R; Gairard A
    Can J Physiol Pharmacol; 1979 Feb; 57(2):157-62. PubMed ID: 546483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
    Lahlou S
    Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that a GABAergic mechanism influences the development of DOCA-salt hypertension in the rat.
    Rotiroti D; Palella B; Losi E; Nistico G; Caputi AP
    Eur J Pharmacol; 1982 Sep; 83(1-2):153-4. PubMed ID: 6813130
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of central serotonin depletion on DOCA-saline hypertension in the rat.
    Myers MG; Reid JL; Lewis PJ
    Cardiovasc Res; 1974 Nov; 8(6):806-10. PubMed ID: 4457231
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of preliminary adaptation to cold on the evolution of DOCA-salt hypertension in rats].
    Barbarash NA; Dvurechenskaia GIa; Gorbunova LA
    Kardiologiia; 1973 Feb; 13(2):86-9. PubMed ID: 4775790
    [No Abstract]   [Full Text] [Related]  

  • 13. Separation of two strains of rats with inbred dissimilar sensitivity to Doca-salt hypertension.
    Ben-Ishay D; Saliternik R; Welner A
    Experientia; 1972 Nov; 28(11):1321-2. PubMed ID: 4638904
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of the adrenal glands in the development of severe hypertension.
    Carretero OA; Enzmann G; Polomski C; Piwonska A; Oza NB; Schork A
    Circ Res; 1973 Nov; 33(5):516-20. PubMed ID: 4752853
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of desoxycorticosterone action. VIII. Effects of nephrectomy.
    GREEN DM; CRAIG RL; SAUNDERS FJ; STURTEVANT FM
    Am J Physiol; 1952 Sep; 170(3):477-85. PubMed ID: 12985920
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
    Rahmouni K; Sibug RM; De Kloet ER; Barthelmebs M; Grima M; Imbs JL; De Jong W
    Eur J Pharmacol; 2002 Feb; 436(3):207-16. PubMed ID: 11858800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of the intimal thickenings produced by hypertension in large arteries in the rat.
    Still WJ
    Lab Invest; 1968 Jul; 19(1):84-91. PubMed ID: 5671356
    [No Abstract]   [Full Text] [Related]  

  • 18. Essential role of kallikrein-kinin system in suppression of blood pressure rise during the developmental stage of hypertension induced by deoxycorticosterone acetate-salt in rats.
    Katori M; Majima M; Mohsin SS; Hanazuka M; Mizogami S; Oh-ishi S
    Agents Actions Suppl; 1992; 38 ( Pt 3)():235-42. PubMed ID: 1281379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of calcium turnover during the onset of mineralocorticoid hypertension in the rat.
    Stoclet JC; Miss-Pagès C; Berthelot A; Gairard A
    Life Sci; 1975 Oct; 17(7):1095-103. PubMed ID: 1195999
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of foetal removal on the blood pressure in steroid hypertensive rats.
    Moore HC; Borvendeg J; Wilson K
    Acta Endocrinol (Copenh); 1971 Jul; 67(3):590-6. PubMed ID: 5108737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.